Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0043167 (
pertussis
)
19,595
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Prokineticin-1
(
PK1
) has been identified as a mitogen-specific protein for the endothelium of steroidogenic glands. Here we report a novel function of
PK1
in the regulation of multiple myeloma (MM) cells.
PK1
activates multiple signals including mitogen-activated protein kinase (MAPK), PI3K-AKT, and Jak-STAT3, sphingosine kinase-1 (SPK1) in MM cells. Treatment of MM cells with
PK1
causes a time- and dose-dependent phosphorylation of MAPK, AKT and STAT3 and upregulation of SPK1 expression and cellular activity. We also show that
PK1
upregulates Mcl-1 expression in a time- and dose-dependent manner in human MM cell lines and in the cells of patients with MM.
Pertussis
toxin, a pan-
PK1
receptor inhibitor, can block
PK1
-induced upregulation of Mcl-1, indicating it relates to a G-protein-coupled receptor. We also show that
PK1
protects MM cells against apoptosis induced by starvation for fetal calf serum (FBS), or for FBS and IL-6. Taken together,
PK1
activates multiple signaling pathways and, upregulates Mcl-1 expression, leading to proliferation and survival of MM cells.
...
PMID:Prokineticin-1/endocrine gland-derived vascular endothelial growth factor is a survival factor for human multiple myeloma cells. 2079 91